Muscle protein alterations in LGMD2I patients with different mutations in the fukutin-related protein gene

Journal of Histochemistry and Cytochemistry

Volumn 56, Issue 11, 2008, Pages 995-1001

  Yamamoto, Lydia U ^a   Velloso, Fernando J ^a   Lima, Bruno L ^a   Fogaça, Luciana L Q ^a   De Paula, Flávia ^a   Vieira, Natássia M ^a   Zatz, Mayana ^a   Vainzof, Mariz ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Fukutin related protein; LGMD2I; Muscle proteins; Muscular dystrophies

Indexed keywords

CALPAIN 3; COLLAGEN TYPE 6; DYSFERLIN; DYSTROPHIN; FUKUTIN RELATED PROTEIN; GALACTOSE; LAMININ ALPHA2; MUSCLE PROTEIN; SARCOGLYCAN; TELETHONIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CELL VACUOLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME DEFICIENCY; FEMALE; GENE MUTATION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; LIMB GIRDLE MUSCULAR DYSTROPHY; LIMB GIRDLE TYPE 21; MALE; MUSCLE; MUSCLE BIOPSY; POPULATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEFICIENCY; SARCOLEMMA; WESTERN BLOTTING;

EID: 54349103953     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/jhc.2008.951772     Document Type: Article

References (30)

1. Beedle AM, Nienaber PM, Campbell KP (2007) Fukutin-related protein associates with the sarcolemmal dystrophin-glycoprotein complex. J Biol Chem 282:16713-16717
2. Brockington M, Blake DJ, Prandini P, Brown SC, Torelli S, Benson MA, Ponting CP, et al. (2001a) Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary α2-laminin deficiency and abnormal glycosylation of α-dystroglycan. Am J Hum Genet 69:1198-1209
3. Brockington M, Blake DJ, Torelli S, Brown CS, Muntoni F (2002) The gene for a novel glycosyltransferase is mutated in congenital muscular dystrophy MDC1C and limp girdle muscular dystrophy 21. Neuromuscul Disord 12:233-234
4. Brockington M, Yuva Y, Prandini P, Brown SC, Torelli S, Benson MA, Herrmann R, et al. (2001b) Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C. Hum Mol Genet 10:2851-2859
5. Brown SC, Torelli S, Brockington M, Yuva Y, Jimenez C, Feng L, Anderson L, et al. (2004) Abnormalities in α-dystroglycan expression in MDC1 and LGMD2I muscular dystrophies. Am J Pathol 164:727-737
6. Bushby KM (1995) Diagnostic criteria for the limb-girdle muscular dystrophies: report of the ENMC Consortium on Limb-Girdle Dystrophies. Neuromuscul Disord 5:71-74
7. Bushby KM, Beckmann JS (2003) The 105th ENMC sponsored workshop: pathogenesis in the non-sarcoglycan limb-girdle muscular dystrophies, Naarden, April 12-14, 2002. Neuromuscul Disord 13:80-90.
8. Cohn RD (2005) Dystroglycan: important player in skeletal muscle and beyond. Neuromuscul Disord 15:207-217
9. de Paula F, Vieira N, Starling A, Yamamoto LU, Lima B, Pavanello RC, Vainzof M, et al. (2003) Asymptomatic carriers for homozygous novel mutations in the FKRP gene: the other end of the spectrum. Eur J Hum Genet 11:923-930
10. Dubowitz V (1999) 68th ENMC international workshop (5th international workshop): on congenital muscular dystrophy, 9-11 April 1999, Naarden, The Netherlands. Neuromuscul Disord 9:446-454
11. Ervasti JM, Campbell KP (1993) A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol 122:809-823
12. Grewal KP, Hewitt JE (2003) Glycosylation defects: a new mechanism for muscular dystrophy? Hum Mol Genet 12:259-264
13. Henry MD, Campbell KP (1999) Dystroglycan inside and out. Curr Opin Cell Biol 11:602-607
14. Hewitt JE, Grewal PK (2003) Glycosylation defects in inherited muscle disease. Cell Mol Life Sci 60:251-258
15. Ibraghimov-Beskrovnaya O, Ervasti JM, Leveille CJ, Slaughter CA, Sernett SW, Campbell KP (1992) Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 355:696-702
16. MacLeod H, Pytel P, Wollmann R, Chelmicka-Schorr E, Silver K, Anderson RB, Waggoner D, et al. (2007) A novel FKRP mutation in congenital muscular dystrophy disrupts the dystrophin glycoprotein complex. Neuromuscul Disord 17:285-289
17. Martin PT (2003) Dystroglycan glycosylation and its role in matrix binding in skeletal muscle. Glycobiology 13:55R-66R
18. Matsumoto H, Hayashi YK, Kim DS, Ogawa M, Murakami T, Nogushi S, Nonaka I, et al. (2005) Congenital muscular dystrophy with glycosylation defects of α-dystroglycan in Japan. Neuromuscul Disord 15:342-348
19. Mercuri E, Brockington M, Straub V, Quijano-Roy S, Yuva Y, Herrrrmann R, Brown SC, et al. (2003) Phenotypic spectrum associated with mutations in the fukutin-related protein gene. Ann Neurol 53:537-542
20. Mercuri E, Topaloglu H, Brockington M, Berardinelli A, Pichiecchio A, Santorelli F, Rutherford M, et al. (2006) Spectrum of brain changes in patients with congenital muscular dystrophy and FKRP gene mutations. Arch Neurol 673:251-257
21. Michele DE, Barresi R, Kanagawa M, Saito F, Cohn RD, Satz JS, Dollar J, et al. (2002) Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature 418:417-422
22. Poppe M, Cree L, Bourke J, Eagle M, Anderson LVB, Birchall D, Brockington M, et al. (2003) The phenotype of limb-girdle muscular dystrophy type 2I. Neurology 60:1246-1251
23. Quijano-Roy S, Carrera IM, Makri S, Mayer M, Maugenre S, Richard P, Berard C, et al. (2006) Brain MRI abnormalities in muscular dystrophy due to FKRP mutations. Brain Dev 28:232-242
24. Schachter H, Vajsar J, Zhang W (2004) The role of defective glycosylation in congenital muscular dystrophy. Glycoconj J 20:291-300
25. Sewry CA, Naom I, D'Alessandro M, Sorokin L, Bruno S, Wilson LA, Dubowitz V, et al. (1997) Variable clinical phenotype in merosin-deficient congenital muscular dystrophy associated with differential immunolabelling of two fragments of the laminin α2 chain. Neuromuscul Disord 7:169-175
26. Topaloglu H, Brockington M, Yuva Y, Talim B, Haliloglu G, Blake D, Torelli S, et al. (2003) FKRP gene mutations cause congenital muscular dystrophy, mental retardation, and cerebellar cysts. Neurology 60:988-992
27. Vainzof M, Passos-Bueno MR, Rapaport D, Pavanello RCM, Bulman DE, Zatz M (1992) Additional dystrophin fragment in Becker muscular dystrphy patients: correlation with the pattern of DNA deletions. Am J Med Genet 44:382-384
28. Vainzof M, Passos-Bueno MR, Zatz M (2003) Immunological methods for the analysis of protein expression in neuromuscular diseases. Methods Mol Biol 217:355-378
29. Vainzof M, Yamamoto LU, Gouveia TLF, Zatz M (2005) The contribution of protein analysis in the diagnosis of neuromuscular diseases. In Burgess VN, ed. Trends in Muscular Dystrophy Research. New York, Nova Biomedical Books, 245-262
30. Wicklund M, Hilton-Jones D (2003) The limb-girdle muscular dystrophies. Genetic and phenotypic definition of a disputed entity. Neurology 60:1230-1231